CSBR:NASDAQ
Champions Oncology Inc
4,34Â USD
arrow_downward
−1,36%(−0,060) 1 D
20. nov., 16:00:00 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Ã…pne
4,45Â USD
Høy
4,45Â USD
Lav
4,34Â USD
Markedsverdi
60,41Â mill.
Snittvolum
6,97k
Volum
8,94k
52 u høy
8,31Â USD
52Â u lav
4,34Â USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92Â mill.
Antall ansatte
217
Ã…pne
4,45Â USD
Høy
4,45Â USD
Lav
4,34Â USD
Markedsverdi
60,41Â mill.
Snittvolum
6,97k
Volum
8,94k
52 u høy
8,31Â USD
52Â u lav
4,34Â USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92Â mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
Trefis
·
for 55 minutter siden
25 S&P 500 Stocks Just Made New 52-Week Lows
Los Angeles Times
·
for 16 timer siden
S&P 500 falls 10% from record, entering correction as AI trade unravels
Barron's
·
for 19 timer siden
S&P 500 Skid Enters Seventh Day as Dow Nears Correction
Scripps News
·
for 4 timer siden
AI stock sell-off sends S&P 500 into correction, Nasdaq negative for year
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com